BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2476601, TGFB1, nitric oxide metabolic process, HIV infection, Lung, Cisplatin)
Bookmark Forward

QuickView for gamma vinyl gaba (compound)


Genetic Markers

Most Correlated Genes

  1. ABAT
  2. THBS1
  3. ATRNL1
  4. RAC3
  5. CG4757
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. HELLER_SILENCED_BY_METHYLATION_UP
  2. GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN
  3. GSE10325_BCELL_VS_MYELOID_DN
  4. GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN
  5. GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug target sets for approved compounds
  2. Broad Connectivity Map (CMAP 2.0) compound database
  3. Expression changes in Drosophila head secondary to vigabatrin during Pentylenetetrazole withdrawal
  4. Cerebrocortical cells treated with blood-brain barrier penetrant clinic-tested drugs
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. A Placebo-Controlled Randomized Trial of Vigabatrin in the Management of Acute Alcohol Withdrawal.
  2. Retinal and Systemic Toxicity of Vigabatrin Is Driven by the S-Enantiomer in the Long Evans Rat.
  3. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epilepti…
  4. Ocular examinations, findings, and toxicity in children taking vigabatrin.
  5. Rapid determination of plasma vigabatrin by LC-ESI-MS/MS supporting therapeutic drug monitoring in c…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism
  2. Effects of Vigabatrin on Cocaine Self-Administration
  3. Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence
  4. Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.